Overexpression of Wnt5a promotes angiogenesis in NSCLC

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Yao, Lingli ^a,b   Sun, Baocun ^a   Zhao, Xiulan ^a   Zhao, Xueming ^a   Gu, Qiang ^a   Dong, Xueyi ^a   Zheng, Yanjun ^a   Sun, Junying ^a   Cheng, Runfen ^a   Qi, Hong ^a   An, Jindan ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; CD31 ANTIGEN; GELATINASE A; GELATINASE B; VASCULAR ENDOTHELIAL CADHERIN; WNT5A PROTEIN; ONCOPROTEIN; WNT PROTEIN; WNT5A PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER PATIENT; CANCER PROGNOSIS; CANCER SURVIVAL; CAPILLARY DENSITY; CLINICAL FEATURE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DISTANT METASTASIS; EVALUATION STUDY; FEMALE; GENDER; GENE OVEREXPRESSION; GENERAL PATHOLOGICAL PARAMETERS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; NEOVASCULARIZATION (PATHOLOGY); PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SURVIVAL TIME; TUMOR DIFFERENTIATION; UPREGULATION; VASCULOGENIC MIMICRY; BIOSYNTHESIS; CARCINOGENESIS; CLASSIFICATION; GENE EXPRESSION REGULATION; GENETICS; MIDDLE AGED; NON SMALL CELL LUNG CANCER; PATHOLOGY; PROGNOSIS; SURVIVAL; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BETA CATENIN; CARCINOGENESIS; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS; PROTO-ONCOGENE PROTEINS; SURVIVAL ANALYSIS; WNT PROTEINS;

EID: 84903643227     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/832562     Document Type: Article

References (42)

1. Siegel R., Ma J., Zou Z., Jemal A., Cancer statistics, 2014. CA: A Cancer Journal for Clinicians 2014 64 9 29 10.3322/caac.21208
2. Beasley M. B., Brambilla E., Travis W. D., The 2004 World Health Organization classification of lung tumors. Seminars in Roentgenology 2005 40 2 90 97 2-s2.0-15744362912 10.1053/j.ro.2005.01.001 (Pubitemid 40417889)
3. Tao L., Huang G., Shi S., Chen L., Bevacizumab improves the antitumor efficacy of adoptive cytokine-induced killer cells therapy in non-small cell lung cancer models. Medical Oncology 2014 31 777 10.1007/s12032-013-0777-3
4. Pircher A., Wasle I. K., Mian M., Gamerith G., Ulsperger E., Studnicka M., Mohn-Staudner A., Hilbe W., Fiegl M., Docetaxel in the treatment of non-small cell lung cancer (NSCLC)-an observational study focusing on symptom improvement. Anticancer Research 2013 33 3831 3836
5. Christodoulou M., Bayman N., McCloskey P., Rowbottom C., Faivre-Finn C., New radiotherapy approaches in locally advanced non-small cell lung cancer. European Journal of Cancer 2014 50 525 534 10.1016/j.ejca.2013.11.027
6. Keedy V. L., Temin S., Somerfield M. R., Beasley M. B., Johnson D. H., McShane L. M., Milton D. T., Strawn J. R., Wakelee H. A., Giaccone G., American Society of clinical oncology provisional clinical opinion: epidermal growth factor receptor (EGFR) mutation testing for patients with advanced non-small-cell lung cancer considering first-line EGFR tyrosine kinase inhibitor therapy. Journal of Clinical Oncology 2011 29 15 2121 2127 2-s2.0-79957492069 10.1200/JCO.2010.31.8923
7. Folkman J., Tumor angiogenesis: therapeutic implications. The New England Journal of Medicine 1971 285 21 1182 1186 2-s2.0-0015231516
8. Folkman J., Angiogenesis in cancer, vascular, rheumatoid and other disease. Nature Medicine 1995 1 1 27 31 2-s2.0-0028929803
9. Park H., Jung H. Y., Choi H. J., Kim D. Y., Yoo J. Y., Yun C. O., Min J. K., Kim Y. M., Kwon Y. G., Distinct roles of DKK1 and DKK2 in tumor angiogenesis. Angiogenesis 2014 17 221 234 10.1007/s10456-013-9390-5
10. Stefater J. A. III, Lewkowich I., Rao S., Mariggi G., Carpenter A. C., Burr A. R., Fan J., Ajima R., Molkentin J. D., Williams B. O., Wills-Karp M., Pollard J. W., Yamaguchi T., Ferrara N., Gerhardt H., Lang R. A., Regulation of angiogenesis by a non-canonical Wnt-Flt1 pathway in myeloid cells. Nature 2011 474 7352 511 516 2-s2.0-79959553858 10.1038/nature10085
11. Masckauchán T. N. H., Agalliu D., Vorontchikhina M., Ahn A., Parmalee N. L., Li C.-M., Khoo A., Tycko B., Brown A. M. C., Kitajewski J., Wnt5a signaling induces proliferation and survival of endothelial cells in vitro and expression of MMP-1 and Tie-2. Molecular Biology of the Cell 2006 17 12 5163 5172 2-s2.0-33845398385 10.1091/mbc.E06-04-0320 (Pubitemid 44907359)
12. Cheng R., Sun B., Liu Z., Zhao X., Qi L., Li Y., Gu Q., Wnt5a suppresses colon cancer by inhibiting cell proliferation and epithelial-mesenchymal transition. Journal of Cellular Physiology 2014 10.1002/jcp.24566
13. Fernandez-Cobo M., Zammarchi F., Mandeli J., Holland J. F., Pogo B. G. T., Expression of Wnt5A and Wnt10B in non-immortalized breast cancer cells. Oncology Reports 2007 17 4 903 907 2-s2.0-34249934694
14. Bo H., Zhang S., Gao L., Chen Y., Zhang J., Chang X., Zhu M., Upregulation of Wnt5a promotes epithelial-to-mesenchymal transition and metastasis of pancreatic cancer cells. BMC Cancer 2013 13, article 496
15. Lee G. T., Kang D. I., Ha Y. S., Jung Y. S., Chung J., Min K., Kim T. H., Moon K. H., Chung J. M., Lee D. H., Kim W. J., Kim I. Y., Prostate cancer bone metastases acquire resistance to androgen deprivation via WNT5A-mediated BMP-6 induction. The British Journal of Cancer 2014 110 1634 1644 10.1038/bjc.2014.23
16. Kanzawa M., Semba S., Hara S., Itoh T., Yokozaki H., WNT5A is a key regulator of the epithelial-mesenchymal transition and cancer stem cell properties in human gastric carcinoma cells. Pathobiology 2013 80 5 235 244 2-s2.0-84876457158 10.1159/000346843
17. Jiang W., Crossman D. K., Mitchell E. H., Sohn P., Crowley M. R., Serra R., WNT5A inhibits metastasis and alters splicing of Cd44 in breast cancer cells. PLoS ONE 2013 8 3 2-s2.0-84874587211 10.1371/journal.pone.0058329 e58329
18. Bi L., Liu X., Wang C., Cao Y., Mao R., Li P., Geng M., Wnt5a involved in regulation of the biological behavior of hepatocellular carcinoma. International Journal of Clinical and Experimental Pathology 2014 7 987 995
19. Yang D.-H., Yoon J.-Y., Lee S.-H., Bryja V., Andersson E. R., Arenas E., Kwon Y.-G., Choi K.-Y., Wnt5a is required for endothelial differentiation of embryonic stem cells and vascularization via pathways involving both Wnt/ β -Catenin and protein kinase C α Circulation Research 2009 104 3 372 379 2-s2.0-61949150215 10.1161/CIRCRESAHA.108.185405
20. Huang C.-L., Liu D., Nakano J., Ishikawa S., Kontani K., Yokomise H., Ueno M., Wnt5a expression is associated with the tumor proliferation and the stromal vascular endothelial growth factor-an expression in non-small-cell lung cancer. Journal of Clinical Oncology 2005 23 34 8765 8773 2-s2.0-33644833865 10.1200/JCO.2005.02.2871 (Pubitemid 46211522)
21. Travis W. D., Brambilla E., Noguchi M., Nicholson A. G., Geisinger K. R., Yatabe Y., Beer D. G., Powell C. A., Riely G. J., Van Schil P. E., Garg K., Austin J. H. M., Asamura H., Rusch V. W., Hirsch F. R., Scagliotti G., Mitsudomi T., Huber R. M., Ishikawa Y., Jett J., Sanchez-Cespedes M., Sculier J.-P., Takahashi T., Tsuboi M., Vansteenkiste J., Wistuba I., Yang P.-C., Aberle D., Brambilla C., Flieder D., Franklin W., Gazdar A., Gould M., Hasleton P., Henderson D., Johnson B., Johnson D., Kerr K., Kuriyama K., Lee J. S., Miller V. A., Petersen I., Roggli V., Rosell R., Saijo N., Thunnissen E., Tsao M., Yankelewitz D., International association for the study of lung cancer/American Thoracic Society/European Respiratory Society international multidisciplinary classification of lung adenocarcinoma. Journal of Thoracic Oncology 2011 6 2 244 285 2-s2.0-79551563284 10.1097/JTO.0b013e318206a221
22. Zhang Y., Sun B., Zhao X., Liu Z., Wang X., Yao X., Dong X., Chi J., Clinical significances and prognostic value of cancer stem-like cells markers and vasculogenic mimicry in renal cell carcinoma. Journal of Surgical Oncology 2013 108 6 414 419 2-s2.0-84883148236 10.1002/jso.23402
23. Sun T., Zhao N., Zhao X.-L., Gu Q., Zhang S.-W., Che N., Wang X.-H., Du J., Liu Y.-X., Sun B.-C., Expression and functional significance of Twist1 in hepatocellular carcinoma: its role in vasculogenic mimicry. Hepatology 2010 51 2 545 556 2-s2.0-75449104452 10.1002/hep.23311
24. Sun T., Sun B.-C., Zhao X.-L., Zhao N., Dong X.-Y., Che N., Yao Z., Ma Y.-M., Gu Q., Zong W.-K., Liu Z.-Y., Promotion of tumor cell metastasis and vasculogenic mimicry by way of transcription coactivation by Bcl-2 and Twist1: a study of hepatocellular carcinoma. Hepatology 2011 54 5 1690 1706 2-s2.0-80055032640 10.1002/hep.24543
25. Bittner M., Meltzer P., Chen Y., Jiang Y., Seftor E., Hendrix M., Radmacher M., Simon R., Yakhini Z., Ben-Dor A., Sampas N., Dougherty E., Wang E., Marincola F., Gooden C., Lueders J., Glatfelter A., Pollock P., Carpten J., Gillanders E., Leja D., Dietrich K., Beaudry C., Berens M., Alberts D., Sondak V., Hayward N., Trent J., Molecular classification of cutaneous malignant melanoma by gene expression profiling. Nature 2000 406 6795 536 540 2-s2.0-0034601455 10.1038/35020115 (Pubitemid 30625740)
26. Lange C., Mix E., Rateitschak K., Rolfs A., Wnt signal pathways and neural stem cell differentiation. Neurodegenerative Diseases 2006 3 1-2 76 86 2-s2.0-33646800545 10.1159/000092097 (Pubitemid 43760372)
27. Herzlinger D., Qiao J., Cohen D., Ramakrishna N., Brown A. M. C., Induction of kidney epithelial morphogenesis by cells expressing Wnt-1. Developmental Biology 1994 166 2 815 818 2-s2.0-0028589430 10.1006/dbio.1994. 1360
28. Dale T. C., Signal transduction by the Wnt family of ligands. Biochemical Journal 1998 329 2 209 223 2-s2.0-0032518695 (Pubitemid 28040782)
29. You Z., Saims D., Chen S., Zhang Z., Guttridge D. C., Guan K.-L., MacDougald O. A., Brown A. M. C., Evan G., Kitajewski J., Wang C.-Y., Wnt signaling promotes oncogenic transformation by inhibiting c-Myc-induced apoptosis. Journal of Cell Biology 2002 157 3 429 440 2-s2.0-0037193466 10.1083/jcb.200201110 (Pubitemid 34839807)
30. Reya T., Clevers H., Wnt signalling in stem cells and cancer. Nature 2005 434 7035 843 850 2-s2.0-17244376814 10.1038/nature03319 (Pubitemid 40558990)
31. Nakashima N., Huang C.-L., Liu D., Ueno M., Yokomise H., Intratumoral Wnt1 expression affects survivin gene expression in non-small cell lung cancer. International Journal of Oncology 2010 37 3 687 694 2-s2.0-77956555479 10.3892/ijo-00000718
32. Heikkil M., Peltoketo H., Vainio S., Wnts and the female reproductive system. Journal of Experimental Zoology 2001 290 6 616 623 2-s2.0-0035506747 10.1002/jez.1112 (Pubitemid 33072713)
33. Kovalchuk O., Ponton A., Filkowski J., Kovalchuk I., Dissimilar genome response to acute and chronic low-dose radiation in male and female mice. Mutation Research 2004 550 1-2 59 72 2-s2.0-2342469838 10.1016/j.mrfmmm.2004.02. 007 (Pubitemid 38595662)
34. Maniotis A. J., Folberg R., Hess A., Seftor E. A., Gardner L. M. G., Pe'er J., Trent J. M., Meltzer P. S., Hendrix M. J. C., Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry. The American Journal of Pathology 1999 155 3 739 752 2-s2.0-0032887340 (Pubitemid 29426820)
35. Du J., Sun B., Zhao X., Gu Q., Dong X., Mo J., Sun T., Wang J., Sun R., Liu Y., Hypoxia promotes vasculogenic mimicry formation by inducing epithelial-mesenchymal transition in ovarian carcinoma. Gynecologic Oncology 2014 10.1016/j.ygyno.2014.02.034
36. Chung H. J., Mahalingam M., Angiogenesis, vasculogenic mimicry and vascular invasion in cutaneous malignant melanoma-implications for therapeutic strategies and targeted therapies. Expert Review of Anticancer Therapy 2014 14 5 621 639 10.1586/14737140.2014.883281
37. Zhang J. T., Sun W., Zhang W. Z., Ge C. Y., Liu Z. Y., Zhao Z. M., Lu X. S., Fan Y. Z., Norcantharidin inhibits tumor growth and vasculogenic mimicry of human gallbladder carcinomas by suppression of the PI3-K/MMPs/Ln-5gamma2 signaling pathway. BMC Cancer 2014 14, article 193 10.1186/1471-2407-14-193
38. Luo F., Yang K., Liu R. L., Meng C., Dang R. F., Xu Y., Formation of vasculogenic mimicry in bone metastasis of prostate cancer: correlation with cell apoptosis and senescence regulation pathways. Pathology: Research and Practice 2014 210 291 295 10.1016/j.prp.2014.01.005
39. Chiablaem K., Lirdprapamongkol K., Keeratichamroen S., Surarit R., Svasti J., Curcumin suppresses vasculogenic mimicry capacity of hepatocellular carcinoma cells through STAT3 and PI3K/AKT inhibition. Anticancer Research 2014 34 1857 1864
40. Chen Y. S., Chen Z. P., Vasculogenic mimicry: a novel target for glioma therapy. Chinese Journal of Cancer 2014 33 74 79 10.5732/cjc.012.10292
41. Liu W.-B., Xu G.-L., Jia W.-D., Li J.-S., Ma J.-L., Chen K., Wang Z.-H., Ge Y.-S., Ren W.-H., Yu J.-H., Wang W., Wang X.-J., Prognostic significance and mechanisms of patterned matrix vasculogenic mimicry in hepatocellular carcinoma. Medical Oncology 2011 28 supplement 1 S228 S238 2-s2.0-79955519883 10.1007/s12032-010-9706-x
42. He X., Saint-Jeannet J.-P., Wang Y., Nathans J., Dawid I., Varmus H., A member of the frizzled protein family mediating axis induction by Wnt-5A. Science 1997 275 5306 1652 1654 2-s2.0-0030941498 10.1126/science.275.5306.1652 (Pubitemid 27120542)